Drug Profile
Research programme: recombinant chorionic gonadotrophin hormone/luteinising hormone therapeutics - Trophogen
Latest Information Update: 12 Sep 2023
Price :
$50
*
At a glance
- Originator Trophogen
- Class Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Infertility
- Discontinued Ovarian cancer
Most Recent Events
- 06 Sep 2023 Discontinued - Preclinical for Ovarian cancer in USA (unspecified route)
- 28 Mar 2020 No recent reports of development identified for preclinical development in Infertility in USA
- 28 Mar 2020 No recent reports of development identified for preclinical development in Ovarian-cancer in USA